Seattle company plays key part in creating breakthrough tuberculosis treatment


A new drug developed has been granted Food and Drug Administration approval — offering hope to patients with drug-resistant tuberculosis.

Previous Silicon Valley stocks flash red as Dow posts worst day of 2019
Next Methodist invests in new tech for area's many stroke patients